Interfering ribonucleic acid (ARNI) compositions and methods for silencing growth factor receptor-bound protein 14 (grb14) in the liver
CO20260014080A2Pending Publication Date: 2026-10-08ALNYLAM PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CO20260014080
- Authority / Receiving Office
- CO · CO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-03-21
- Filing Date
- 2026-09-25
- Publication Date
- 2026-10-08
Abstract
The description relates to double-stranded ribonucleic acid (dhRNA) compositions targeting the GRB14 gene, as well as methods for inhibiting GRB14 expression, and methods for treating subjects who would benefit from a reduction in GRB14 expression, such as subjects who have a GRB14-associated disease, disorder, or condition, such as diabetes, using these dhRNA compositions.
Need to check novelty before this filing date? Find Prior Art